PubMed Health⌕ Search

PubMed · 11780299

Airway stenting.

Abstract

Various airway pathologies may result in central airway obstruction. For patients who have benign and malignant disease, definitive surgical correction by tracheobronchial resection and reconstruction is preferred. Numerous patients, however, have unresectable airway lesions owing to the extent of disease or to medical or surgical contraindications. These patients can be palliated by several endoscopic strategies, including dilatation, core out of tumor, laser resection, endobronchial brachytherapy, or photodynamic therapy. Airway stenting with silicone or expandable metal stents provides reliable and durable palliation in 80% to 95% of properly selected patients. The major advantages of silicone stents are the ease of customization, repositioning, and removal, with the major drawbacks being stent migration or stent obstruction. Expandable metal stents have the advantage of ease of insertion, conformation to the airway, low inner-to-outer diameter ratio, and stent stability. These advantages, however, are offset by (1) the development of tumor ingrowth or of granulation at the end of the stent or through the interstices of the stent and (2) the difficulty or impossibility of stent repositioning or removal once it has been seated completely within the airway. Management of the patient who has central airway obstruction requires a thorough knowledge and consideration of the surgical and endoscopic management options and, usually, a multidisciplinary approach, with experienced thoracic surgical consultation to evaluate the potential for definitive surgical correction. The interventional bronchoscopist must consider the spectrum of endoscopic therapeutics fully. Most patients benefit from combining strategies in a flexible algorithm directed at optimizing patient outcomes. The benefits and risks of airway stenting must be considered in comparison with the other options for airway palliation. In refractory strictures, rapidly recurrent tumor, or extrinsic compression, endobronchial stenting likely will be necessary to achieve durable palliation of airway obstruction. The short- and long-term implications of airway stenting, including the complications of silicone versus expandable metal stents, should be considered thoroughly, while the physician bases treatment or procedure decisions on individual patient anatomy and expected natural history.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D E Wood. 2001. Airway stenting.. https://pubmed.ncbi.nlm.nih.gov/11780299/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Thyroid involvement with Langerhans cell histiocytosis in a 3-year-old male.

We report on the thyroid involvement with Langerhans cell histiocytosis (LCH) in a 3-year-old male. The patient presented with goiter and primary hypothyroidism. His goiter caused life-threatening airway obstruction. He developed locally invasive disease 4 years after his response to LCH therapy. LCH should be suspected as a cause of goiter and thyroidectomy is recommended.

Airway Obstruction↗

Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex--a hypothetical review.

Obstructive sleep apnea (OSA) and asthma are potentially linked at several levels. The pathophysiology of these two conditions seems to overlap significantly, as airway obstruction, inflammation, obesity, and several other factors are implicated in the development of both diseases. Gastroesophageal reflux disease (GERD), cardiovascular complications, obesity itself, and the underlying inflammatory processes are all complex contributory factors that provide hypothetical links. Furthermore, a collateral rise in prevalence of both OSA and asthma has been noticed during the past few years, occurring in association with the emerging epidemic of obesity, a common risk factor for both conditions. OSA and asthma share many other risk factors as well. We propose a hypothetical OSA-asthma relationship that has implications on the diagnosis and management of patients presenting with either condition singly. Clinicians should be aware that OSA might complicate asthma management. Based on this hypothesis, we suggest that the treatment of the individual patient who experiences both asthma and OSA needs to be multidisciplinary and comprehensive. This hypothetical association of asthma and OSA, though described anecdotally, has not been systematically studied. In particular, the influence of continuous positive airway pressure therapy (for sleep apnea) on asthma outcomes (such as quality of life, steroid utilization, emergency room visits) and fatality needs to be studied further.

Airway Obstruction↗

Managing isolated subglottic juvenile xanthogranuloma without tracheostomy: case report and review of literature.

Juvenile Xanthogranuloma (JXG) is a dendritic cell related histiocytic disorder which usually presents in the first year of life as a solitary cutaneous granuloma. Isolated presentation in the upper airway is very rare but can result in severe respiratory distress, especially in young children. We present the case of a 5-month-old male with an isolated subglottic JXG lesion. Endoscopic excision provided symptomatic relief and avoided the need for tracheostomy. The lesion has completely resolved 17 months later. Surgical excision without tracheostomy was the treatment of choice in two of the four additional cases of upper airway JXG presented in the literature. JXG has an excellent prognosis with spontaneous regression over time. Histology alone is frequently inadequate to differentiate JXG from the more common Langerhans Cell Histiocytosis (LCH), which carries a much less favorable prognosis. The evolving field of immunohistochemistry provides an essential tool to establish the correct diagnosis. The typical phenotype of JXG is Factor XIIIa+/Fascin+/CD68+/CD163+/CD14+/CD1a-/S100-.

Airway Obstruction↗